NCT07179224 - EEG Changes After rTMS Stimulation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 17, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Brain Electrical Reactivity to BTL-699-2 Stimulation

Interventions

DEVICE

Treatment with EXOMIND (BTL-699-2)

Transcranial magnetic stimulation with the EXOMIND (BTL-699-2) device will be delivered across various stimulation locations. The intensity will be carefully adjusted based on subject feedback, but it should not exceed 70% of the motor threshold.

Trial Locations (1)

162 00

RECRUITING

DP Neuro s.r.o., Prague

All Listed Sponsors

lead

BTL Industries Ltd.

INDUSTRY